Ann Duerr

Ann Duerr, MD, PhD, MPH, is a Professor at Fred Hutchinson Cancer Center with appointments spanning the Vaccine and Infectious Disease Division, Public Health Sciences Division, and Clinical Research Division. She concurrently serves as an Affiliate Professor and Graduate Faculty member in Epidemiology and Global Health at the University of Washington and directs scientific affairs for the HIV Vaccine Trials Network.

Her academic foundation includes:

• BS in Biochemistry, McGill University, 1974
• PhD in Biology, Massachusetts Institute of Technology, 1981
• MD cum laude, Harvard University Medical School, 1985
• MPH, Johns Hopkins University School of Hygiene and Public Health, 1988

Dr. Duerr's research pioneers multidisciplinary approaches to HIV prevention and treatment in resource-constrained environments, with concentrated focus on sexual transmission dynamics, acute infection impacts, and antiretroviral therapy optimization among marginalized populations including transgender communities in Peru. Her methodology integrates sexual-network analysis, cost-effectiveness modeling, and laboratory investigations of HIV reservoirs and inflammation.

She directs the University of Washington's Strategic Analysis, Research & Training Center, delivering research consulting to the Gates Foundation and WHO through graduate student-led teams. Current initiatives address UNAIDS 90-90-90 target achievement, HIV transmission interruption among high-risk groups, and early ART intervention strategies amid substance use.